2018 Annual Review of Diseases Prioritized Under the Research and Development Blueprint
2018
This report from the World Health Organization (WHO) details a 2018 annual meeting held to review the list of research and development priorities, as determined by the WHO Blueprint. The Blueprint—a cross-sectoral tool developed by WHO—“seeks to identify those diseases that pose a public health risk because of their epidemic potential and for which there are no, or insufficient, countermeasures.” The meeting convened experts in the field and determined there is a need for increased research and development for the following nine diseases:
- Crimean-Congo Haemorrhagic Fever (CCHF)
- Zika
- Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS)
- Ebola Virus Disease and Marburg Virus Disease
- Lassa Fever
- Nipah and Henipaviral Diseases
2018 Annual Review of Diseases Prioritized Under the Research and Development Blueprint
Source:
Report. 2018 Annual Review of Diseases Prioritized Under the Research and Development Blueprint. World Health Organization 2018. https://cdn.who.int/media/docs/default-source/blue-print/2018-annual-review-of-diseases-prioritized-under-the-research-and-development-blueprint.pdf?sfvrsn=4c22e36_2.